Literature DB >> 20096661

The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells.

Jian-Chien Dominic Heng1, Bo Feng, Jianyong Han, Jianming Jiang, Petra Kraus, Jia-Hui Ng, Yuriy L Orlov, Mikael Huss, Lin Yang, Thomas Lufkin, Bing Lim, Huck-Hui Ng.   

Abstract

Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) with the introduction of Oct4, Sox2, Klf4, and c-Myc. Among these four factors, Oct4 is critical in inducing pluripotency because no transcription factor can substitute for Oct4, whereas Sox2, Klf4, and c-Myc can be replaced by other factors. Here we show that the orphan nuclear receptor Nr5a2 (also known as Lrh-1) can replace Oct4 in the derivation of iPSCs from mouse somatic cells, and it can also enhance reprogramming efficiency. Sumoylation mutants of Nr5a2 with enhanced transcriptional activity can further increase reprogramming efficiency. Genome-wide location analysis reveals that Nr5a2 shares many common gene targets with Sox2 and Klf4, which suggests that the transcription factor trio works in concert to mediate reprogramming. We also show that Nr5a2 works in part through activating Nanog. Together, we show that unrelated transcription factors can replace Oct4 and uncovers an exogenous Oct4-free reprogramming code. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20096661     DOI: 10.1016/j.stem.2009.12.009

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  215 in total

Review 1.  Using human pluripotent stem cells to untangle neurodegenerative disease mechanisms.

Authors:  Brigitte Malgrange; Laurence Borgs; Benjamin Grobarczyk; Audrey Purnelle; Patricia Ernst; Gustave Moonen; Laurent Nguyen
Journal:  Cell Mol Life Sci       Date:  2010-10-26       Impact factor: 9.261

Review 2.  Mechanism and methods to induce pluripotency.

Authors:  Peizhe Wang; Jie Na
Journal:  Protein Cell       Date:  2011-11-06       Impact factor: 14.870

Review 3.  Delineating nuclear reprogramming.

Authors:  Jolene Ooi; Pentao Liu
Journal:  Protein Cell       Date:  2012-03-31       Impact factor: 14.870

Review 4.  Pluripotent stem cells: origin, maintenance and induction.

Authors:  Maria P De Miguel; Sherezade Fuentes-Julián; Yago Alcaina
Journal:  Stem Cell Rev Rep       Date:  2010-12       Impact factor: 5.739

5.  Induction of pluripotent stem cells from human third molar mesenchymal stromal cells.

Authors:  Yasuaki Oda; Yasuhide Yoshimura; Hiroe Ohnishi; Mika Tadokoro; Yoshihiro Katsube; Mari Sasao; Yoko Kubo; Koji Hattori; Shigeru Saito; Katsuhisa Horimoto; Shunsuke Yuba; Hajime Ohgushi
Journal:  J Biol Chem       Date:  2010-07-01       Impact factor: 5.157

Review 6.  Emerging actions of the nuclear receptor LRH-1 in the gut.

Authors:  Pablo J Fernandez-Marcos; Johan Auwerx; Kristina Schoonjans
Journal:  Biochim Biophys Acta       Date:  2010-12-29

Review 7.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

8.  Commentary: the year in nuclear receptor control of metabolism.

Authors:  David J Mangelsdorf
Journal:  Mol Endocrinol       Date:  2010-09-29

Review 9.  Differentiation of mesenchymal stem cells into gonad and adrenal steroidogenic cells.

Authors:  Takashi Yazawa; Yoshitaka Imamichi; Kaoru Miyamoto; Akihiro Umezawa; Takanobu Taniguchi
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

10.  LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancer.

Authors:  S Wang; Z Zou; X Luo; Y Mi; H Chang; D Xing
Journal:  Oncogene       Date:  2018-03-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.